Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 May;28(2):233–240.

The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.

P Hughes, S Holt, N R Rowell, I D Allonby, K Janis, J K Dodd
PMCID: PMC1540753  PMID: 301448

Abstract

Phytohaemagglutinin-induced lymphocyte transformation and circulating thymus-dependent (T) lymphocyte numbers were studied in twenty-eight patients with systemic sclerosis (SS), in fifty normal controls and eleven elderly controls. Patients with SS were found to have impaired lymphocyte transformation responses which showed a positive correlation with both the number of circulating T lymphocytes and the extent of visceral involvement by the disease. This defect of cell-mediated immunity could not be attributed to the effects of increasing age, corticosteroid treatment, iron and folate deficiency or inhibitory serum factors and may have pathogenetic implications for the disorder.

Full text

PDF
238

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón-Segovia D., Fishbein E., García-Ortigoza E., Estrada-Parra S. Uracil-specific anti-R.N.A. antibodies in scleroderma. Lancet. 1975 Feb 15;1(7903):363–366. doi: 10.1016/s0140-6736(75)91279-9. [DOI] [PubMed] [Google Scholar]
  2. Anthony H. M., Kirk J. A., Madsen K. E., Mason M. K., Templeman G. H. E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG. Clin Exp Immunol. 1975 Apr;20(1):41–54. [PMC free article] [PubMed] [Google Scholar]
  3. BECK J. S., ANDERSON J. R., GRAY K. G., ROWELL N. R. ANTINUCLEAR AND PRECIPITATING AUTOANTIBODIES IN PROGRESSIVE SYSTEMIC SCLEROSIS. Lancet. 1963 Dec 7;2(7319):1188–1190. [PubMed] [Google Scholar]
  4. BUNIM J. J. A broader spectrum of Sjogren's syndrome and its pathogenetic implications. Ann Rheum Dis. 1961 Mar;20:1–10. doi: 10.1136/ard.20.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chretien P. B., Crowder W. L., Gertner H. R., Sample W. F., Catalona W. J. Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients. Surg Gynecol Obstet. 1973 Mar;136(3):380–384. [PubMed] [Google Scholar]
  6. Currie S., Saunders M., Knowles M. Immunological aspects of systemic sclerosis in vitro activity of lymphocytes from patients with the disorder. Br J Dermatol. 1971 May;84(5):400–409. doi: 10.1111/j.1365-2133.1971.tb02523.x. [DOI] [PubMed] [Google Scholar]
  7. Gross R. L., Reid J. V., Newberne P. M., Burgess B., Marston R., Hift W. Depressed cell-mediated immunity in megaloblastic anemia due to folic acid deficiency. Am J Clin Nutr. 1975 Mar;28(3):225–232. doi: 10.1093/ajcn/28.3.225. [DOI] [PubMed] [Google Scholar]
  8. Hard R. C., Jr Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells. Clin Exp Immunol. 1975 Nov;22(2):330–340. [PMC free article] [PubMed] [Google Scholar]
  9. Hughes P., Holt S., Rowell N. R., Dodd J. Thymus-dependent (T) lymphocyte deficiency in progressive systemic sclerosis. Br J Dermatol. 1976 Nov;95(5):469–473. doi: 10.1111/j.1365-2133.1976.tb00855.x. [DOI] [PubMed] [Google Scholar]
  10. Hughes P., Holt S., Rowell N. R. Leukocyte migration inhibition in progressive systemic sclerosis. Br J Dermatol. 1974 Jul;91(1):1–6. doi: 10.1111/j.1365-2133.1974.tb06709.x. [DOI] [PubMed] [Google Scholar]
  11. Joynson D. H., Walker D. M., Jacobs A., Dolby A. E. Defect of cell-mediated immunity in patients with iron-deficiency anaemia. Lancet. 1972 Nov 18;2(7786):1058–1059. doi: 10.1016/s0140-6736(72)92340-9. [DOI] [PubMed] [Google Scholar]
  12. Junge U., Hoekstra J., Wolfe L., Deinhardt F. Microtechnique for quantitative evaluation of in vitro lymphocyte transformation. Clin Exp Immunol. 1970 Sep;7(3):431–437. [PMC free article] [PubMed] [Google Scholar]
  13. Millbank L., Davis R. E., Rawlins M., Waters A. H. Automation of the assay of folate in serum and whole blood. J Clin Pathol. 1970 Feb;23(1):54–59. doi: 10.1136/jcp.23.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. SHEARN M. A. Sjogren's syndrome in association with scleroderma. Ann Intern Med. 1960 Jun;52:1352–1362. doi: 10.7326/0003-4819-52-6-1352. [DOI] [PubMed] [Google Scholar]
  15. STASTNY P., STEMBRIDGE V. A., ZIFF M. HOMOLOGOUS DISEASE IN THE ADULT RAT, A MODEL FOR AUTOIMMUNE DISEASE. I. GENERAL FEATURES AND CUTANEOUS LESIONS. J Exp Med. 1963 Oct 1;118:635–648. doi: 10.1084/jem.118.4.635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. TUFFANELLI D. L. Scleroderma and its relationship to the "collagenoses": dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Am J Med Sci. 1962 Feb;243:133–146. [PubMed] [Google Scholar]
  17. Winkelstein A., Rodnan G. P., Heilman J. D. Cellular immunity in progressive systemic sclerosis (scleroderma). Ann Rheum Dis. 1972 Mar;31(2):126–128. doi: 10.1136/ard.31.2.126. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES